CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 227 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66 | -35.3% | 2,424 | -47.3% | 0.03% | -46.3% |
| Q2 2023 | $102 | -77.5% | 4,602 | -79.4% | 0.05% | -82.4% |
| Q4 2022 | $453 | -77.4% | 22,314 | +37720.3% | 0.31% | +6040.0% |
| Q3 2022 | $2,000 | -98.2% | 59 | -98.8% | 0.01% | -95.0% |
| Q1 2022 | $112,000 | +229.4% | 4,980 | +225.7% | 0.10% | +197.1% |
| Q2 2021 | $34,000 | -89.3% | 1,529 | -88.6% | 0.03% | -90.3% |
| Q1 2021 | $319,000 | +3887.5% | 13,419 | +2531.2% | 0.35% | +4275.0% |
| Q3 2020 | $8,000 | – | 510 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,825,262 | $138,621 | 7.54% |
| Novo Holdings A/S | 3,377,768 | $68,602,468 | 4.28% |
| Parallel Advisors, LLC | 3,724,664 | $75,647,926 | 3.28% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $722 | 2.29% |
| Quantedge Capital Pte Ltd | 251,312 | $5,104,147 | 1.71% |
| S&T BANK/PA | 346,306 | $7,033 | 1.30% |
| Freshford Capital Management, LLC | 249,000 | $5,057,190 | 1.09% |
| Birchview Capital, LP | 50,000 | $1,016 | 0.72% |
| FAS Wealth Partners, Inc. | 306,276 | $6,220,466 | 0.70% |
| Bridge City Capital, LLC | 60,824 | $1,235 | 0.63% |